# ZW25 in Women With Endometrial Cancers

> **NCT04513665** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 16 (actual)

## Conditions studied

- Endometrial Cancer
- Carcinosarcoma

## Interventions

- **DRUG:** ZW25

## Key facts

- **NCT ID:** NCT04513665
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-12
- **Primary completion:** 2024-03-08
- **Final completion:** 2024-03-08
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04513665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04513665, "ZW25 in Women With Endometrial Cancers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04513665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*